Category: online filme stream

Jan krauter

Jan Krauter Wirkt mit bei:

Jan Lennart Krauter ist ein deutscher Schauspieler. Jan Lennart Krauter (* in Wilhelmshaven) ist ein deutscher Schauspieler. Inhaltsverzeichnis. 1 Leben; 2 Filmografie (Auswahl); 3 Hörfunk-Features / -. Jan Krauter ist ein deutscher Schauspieler. Regie Judith Kennel (Network Movie), ZDF. 18 - Krieg der Träume. Regie Jan Peter, Frédéric Goupil, ZDF. Jan Krauter. Berlin cm blaugrün aschblond. Englisch, Französisch (GK​) Norddeutsch Wing Tsun, Aikido, Eskrima, Fechten, Schwertkampf, Akrobatik. Jan Krauter. Gefällt Mal. Hier erfahren sie alle Neuigkeiten über den Schauspieler Jan Krauter und können sich über aktuelle Vorstellungs- und.

jan krauter

jan krauter schmied. Jan Krauter. Gefällt Mal. Hier erfahren sie alle Neuigkeiten über den Schauspieler Jan Krauter und können sich über aktuelle Vorstellungs- und. Jan Krauter. Share. Vita as. © Christine Fenzl. 9 Leading role Jan Peter, Fréderic Goupil TV Channel: ZDF. Solo für Weiss - Vergib uns unsere Schuld. Biografie und Filmografie: Jan Krauter, bürgerlich Jan Lennart Krauter, ist ein deutscher Schauspieler. Seine Schauspielausbildung absolvierte er von bis. Profil von Jan Krauter mit Agentur, Kontakt, Vita, Demoband, Showreel, Fotos auf CASTFORWARD, der Online Casting Plattform. Jan Krauter - Alle Bilder, Filme, TV Serien und Fakten finden Sie hier zum Star auf TV Spielfilm. Jetzt hier informieren! Jan Krauter, geboren in Wilhelmshaven, studierte von 20an der Hochschule für Musik und Darstellende Kunst Stuttgart. Für seine Darstellung des. Jan Krauter. Share. Vita as. © Christine Fenzl. 9 Leading role Jan Peter, Fréderic Goupil TV Channel: ZDF. Solo für Weiss - Vergib uns unsere Schuld.

Jan Krauter Video

Kevin Krauter - Green Eyes jan krauter Remarkable www.spiegel.de confirm wurde er mit dem Solopreis als "Bester Schauspieler" beim Theatertreffen Deutschsprachiger Schauspielstudierender in Rostock ausgezeichnet. Zwischen Himmel und HölleHistorienfilm. Jan Krauter im TV. Here Brocken source Der BankraubKrimi. Link Abbruch. Deutschland 86Fernsehserie. Jan Krauter lebt in Berlin. Vita - Theater Jahr.

Thus P values close to. Third, we excluded patients with severe dehydration, as discussed previously. Future studies should include careful measurement of oral intake.

In conclusion, our results suggest that in patients with advanced cancer who are mildly to moderately dehydrated and within days to weeks of death, parenteral hydration at 1, mL per day does not improve symptoms associated with dehydration, QoL, or survival as compared with placebo.

Our study supports current hospice practice of not administering hydration routinely. Further studies are required to determine whether any subgroups, such as delirious patients or those with longer survival, would benefit from parenteral hydration.

Supported by Grant No. CA , an institutional startup fund D. The sponsor of the study had no role in study design, data collection, analysis, interpretation, or writing of the report.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

Conception and design: Eduardo Bruera, J. Lynn Palmer. National Center for Biotechnology Information , U.

J Clin Oncol. Published online Nov Find articles by Eduardo Bruera. Find articles by David Hui.

Find articles by Shalini Dalal. Find articles by Isabel Torres-Vigil. Find articles by Joseph Trumble. Find articles by Joseph Roosth.

Find articles by Susan Krauter. Find articles by Carol Strickland. Find articles by Kenneth Unger.

Find articles by J. Find articles by Julio Allo. Find articles by Susan Frisbee-Hume. Find articles by Kenneth Tarleton. Author information Copyright and License information Disclaimer.

This article has been cited by other articles in PMC. Associated Data Supplementary Materials Protocol. Abstract Purpose The vast majority of patients with cancer at the end of life receive parenteral hydration in hospitals and no hydration in hospice, with limited evidence supporting either practice.

Patients and Methods We randomly assigned patients with cancer from six hospices to receive parenteral hydration normal saline 1 L per day or placebo normal saline mL per day daily over 4 hours.

Conclusion Hydration at 1 L per day did not improve symptoms, quality of life, or survival compared with placebo.

Study Design and Interventions In this randomized, placebo-controlled, double-blind, multicenter study, eligible patients were stratified according to the accrual site.

Study Assessments and End Points Symptom burden, including fatigue, myoclonus, sedation, hallucinations, pain, nausea, depression, anxiety, drowsiness, shortness of breath, appetite, feelings of well-being, and sleep, was assessed using the Edmonton Symptom Assessment Scale ESAS , which has been validated in the cancer population.

Statistical Analysis A planned sample size of patients 75 per arm was powered to detect an effect size difference between the two study arms of 0.

Open in a separate window. Fig 1. Table 1. Baseline Patient Characteristics. Table 2. Table 3.

Hydration Status The dehydration assessment scale improved from baseline in both hydration and placebo groups at day 4, although this was not observed at day 7 Table 2.

Fig 2. Supplementary Material Protocol: Click here to view. Acknowledgment We thank Janet Williams for her assistance with database management.

Footnotes Supported by Grant No. Is there a role for hydration at the end of life? Curr Opin Support Palliat Care.

Dalal S, Bruera E. Dehydration in cancer patients: To treat or not to treat. J Support Oncol, Effects of parenteral hydration in terminally ill cancer patients: A preliminary study.

Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage. Changing pattern of agitated impaired mental status in patients with advanced cancer: Association with cognitive monitoring, hydration, and opioid rotation.

Association between hydration volume and symptoms in terminally ill cancer patients with abdominal malignancies. Ann Oncol.

Volume of hydration in terminal cancer patients. Support Care Cancer. Symptomatology of cancer patients in palliative care: Content validation of self-assessment questionnaires against medical records.

Eur J Cancer. Edmonton symptom assessment scale: Italian validation in two palliative care settings.

The Unified Myoclonus Rating Scale. Adv Neurol. Clinical utility, factor analysis, and further validation of the memorial delirium assessment scale in patients with advanced cancer: Assessing delirium in advanced cancer.

The Richmond Agitation-Sedation Scale: Validity and reliability in adult intensive care unit patients. Serial administration of a modified Richmond Agitation and Sedation Scale for delirium screening.

J Hosp Med. Impact on delirium detection of using a sensitive instrument integrated into clinical practice. Gen Hosp Psychiatry.

The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. Axillary sweating in clinical assessment of dehydration in ill elderly patients.

Clinical indicators of dehydration severity in elderly patients. J Emerg Med. The rational clinical examination.

Is this patient hypovolemic? Assessing the minimal important difference in symptoms: A comparison of two techniques. J Clin Epidemiol.

The use of hypodermoclysis for rehydration in terminally ill cancer patients. Reiff TR. Water and aging.

Clin Geriatr Med. The meaning of parenteral hydration to family caregivers and patients with advanced cancer receiving hospice care.

Action of oral methylprednisolone in terminal cancer patients: A prospective randomized double-blind study.

Cancer Treat Rep. Dexamethasone in addition to metoclopramide for chronic nausea in patients with advanced cancer: A randomized controlled trial.

Methylphenidate associated with narcotics for the treatment of cancer pain. Donepezil for cancer fatigue: A double-blind, randomized, placebo-controlled trial.

Occurrence, causes, and outcome of delirium in patients with advanced cancer: A prospective study. Arch Intern Med. Terminal delirium: Families' experience.

Palliat Med. Family-perceived distress from delirium-related symptoms of terminally ill cancer patients. Impact of delirium and recall on the level of distress in patients with advanced cancer and their family caregivers.

Increased plasma morphine metabolites in terminally ill cancer patients with delirium: An intra-individual comparison. Lawlor PG. The panorama of opioid-related cognitive dysfunction in patients with cancer: A critical literature appraisal.

A multicomponent intervention to prevent delirium in hospitalized older patients. Creators: Gunnar Dedio , Jan Peter. Added to Watchlist.

Top-Rated Episodes S1. Error: please try again. Everything New on Netflix in June. The War Movies. Watched in Best Mini Series.

Start , wishlist TV Shows. Use the HTML below. You must be a registered user to use the IMDb rating plugin.

Episodes Seasons. Hans Beimler 5 episodes, Michalina Olszanska May Picqueray 3 episodes, Natalia Witmer Marina Yurlova 3 episodes, Joel Basman Silvio Crespi 3 episodes, Luc Feit Heester 3 episodes, Thomas Arnold Marcel Jamet 3 episodes, Roxane Duran Edith Wellspacher 3 episodes, Emilie Gavois-Kahn Doriane Jamet 3 episodes, Philip York David Baron Redsdale 3 episodes, Jude Mack Diana Mitford 3 episodes, Jean-Marc Roulot Jean de l'Hermitage 3 episodes, Malgorzata Zajaczkowska Eleonora 3 episodes, Wolfgang Menardi Max Wachstein 3 episodes, Charlotte Merriam Elise Ottesen 2 episodes, Alexandre Nguyen Nguyen Ai Quoc 2 episodes, Anne Kulbatzki Magdalena Müller 2 episodes, Shanti Roney Albert 2 episodes, Roland Bonjour Ernst Lubitsch 2 episodes, Jules Werner Rut 2 episodes, Pyotr Skvortsov Stepan Podlubny 2 episodes, Gemma Lawrence Jessica Mitford 2 episodes, Andreas Lust Adalbert Springer 2 episodes, Gotthard Lange Film Agent 2 episodes, Alexandre Marine Napadov 2 episodes, Pit Bukowski Zabel 2 episodes, Evelyn Plank Heinrich Himmler 2 episodes, Stefan Puntigam Learn more More Like This.

Drama History War. Biography War. Koronatsiya TV Mini-Series Drama History Thriller. Stars: Lars Eidinger, Michalina Olszanska.

The Turncoat Stefan Zweig: Farewell to Europe Certificate: Tous publics Biography Drama History.

Babylon Berlin TV Series Crime Drama Thriller. American Dynasties: The Kennedys La belle vie Adventure Drama Romance.

Die Deutschen TV Series Documentary History. Time Thieves Stars: Anna, Bernadette, Magali Combal. Sandra Drama Mystery War. Was this review helpful to you?

Yes No Report this. Add the first question. Edit Details Official Sites: Official site. Country: Germany Austria France Luxembourg. Runtime: 52 min.

Sound Mix: Stereo. Color: Color. Edit page. Add episode. Clear your history. Hans Beimler 5 episodes, Pola Negri 5 episodes, May Picqueray 3 episodes, Marina Yurlova 3 episodes,

Watched in Suggest fussball live sehen was Zweig: Farewell to Europe The story of a single mother struggling to regain control of her life. This tool has been used in a number of symptom researches. Film Agent 2 episodes, Alexandre Marine This could be done by either obtaining informed consent before this complication occurs or by using proxy this web page. A higher score indicates a higher level of dehydration.

Jan Krauter - Bilder von Jan Krauter

Cursed — Die Auserwählte: Die ersten Bilder. Geboren , Deutschland, Niedersachsen. Woyzeck Staatstheater Stuttgart. Doch unterwegs lauern jede Menge Gefahren auf sie.

Jan Krauter Video

La Boom - Atarihuana (2002) - 08 Kräuter der Provinz Jan Krauter Erinnerung https://pensionat-alvaret.se/serien-stream-deutsch/burning-series-vampire-diaries-staffel-2.php. Hier erhaltet ihr Informationen zu einer Vielzahl von deutschen und deutschsprachigen Filmen. Ratgeber für den intelligenten Homosexuellen zu Sozialismus und Kapitalismus mit Schlüssel zur heiligen Schrift Staatstheater Stuttgart. Gar nicht so einfach, denn learn more here warten so manche Hindernisse darauf, überwunden zu werden. Richard Gere und Sean Connery in diesem Klassiker von

All patients provided written informed consent. In this randomized, placebo-controlled, double-blind, multicenter study, eligible patients were stratified according to the accrual site.

Using a computer-generated simple randomization scheme, the study pharmacist randomly assigned patients in a ratio to receive either 1, mL hydration group or mL placebo group of normal saline at home infused subcutaneously over 4 hours daily until the patient was unresponsive, developed progressive coma, or died.

A volume of 1, mL per day was chosen on the basis of previous studies demonstrating that this amount was adequate to improve clinical outcomes in palliative care patients.

Both the patient and research nurse conducting the study assessments were blinded to the study intervention and the randomization sequence.

Blinding was achieved by having a separate infusion research nurse who was aware of the treatment assignment, set the infusion at the appropriate rate, covered and placed the infusion pump in a locked backpack, and started the infusion at the patient's home each day.

Blinding was further assured by the use of identical backpacks, counter weight g in the placebo backpack, and concealment of the rate of infusion on the infusion pump by a tape.

At the end of study, we asked patients about their perception of study arm they have been assigned to hydration, placebo, or do not know.

Symptom burden, including fatigue, myoclonus, sedation, hallucinations, pain, nausea, depression, anxiety, drowsiness, shortness of breath, appetite, feelings of well-being, and sleep, was assessed using the Edmonton Symptom Assessment Scale ESAS , which has been validated in the cancer population.

Patients were asked to rate the severity of their symptoms over the previous 24 hours using a numerical rating scale of 0 to 10, with 0 meaning that the symptom is absent and 10 meaning the worst possible symptom.

Other secondary outcomes included delirium, QoL, and overall survival. MDAS is a validated, clinician-rated rating scale. It consists of 10 items; each is scored from 0 to 3, with a diagnostic cutoff score of 7 of 30 or above supporting the presence of delirium.

Five symptoms disorientation, inappropriate behavior, inappropriate communication, illusions or hallucinations, and psychomotor retardation are each give a score from 0 to 2, for a total score of The fatigue subscale consists of 13 items.

A higher score indicates a higher level of dehydration. We also collected electrolytes, creatinine, and urea.

Global symptom evaluation was used to estimate the minimal important difference in symptoms fatigue, myoclonus, sedation, hallucinations, and delirium before and after treatment.

Patients were asked about their symptoms worse, about the same, or better after starting treatment. This tool has been used in a number of symptom researches.

Overall survival was defined as time from study enrollment to last date of follow-up or death. A planned sample size of patients 75 per arm was powered to detect an effect size difference between the two study arms of 0.

Because of funding limitations, this study was terminated after patients were enrolled. We summarized the baseline demographics and symptom profile using descriptive statistics, including medians, means, standard deviations, ranges, interquartile ranges, and frequencies.

Intention-to-treat analysis was conducted to compare the change between the two arms using the t test for continuous variables that were normally distributed ie, ESAS , the Mann-Whitney U test for continuous, nonparametric variables eg, NuDESC , and the Fisher's exact test for categorical variables eg, global symptom evaluation.

A two-sided P value of less than. We used the Kaplan-Meier method and log-rank test for survival analysis. SPSS version Figure 1 shows the study flowchart.

Baseline patient characteristics were similar between the two study arms Table 1. We asked patients and caregivers to guess the treatment assignment to check the effectiveness of blinding.

However, there were no significant differences between groups for the change in the sum of four dehydration symptoms or any individual symptoms Table 2.

By day 7, we found no significant improvements in the sum of four dehydration symptoms from baseline in either groups.

However, we found no significant differences between the two groups for the change in the sum of four dehydration symptoms or for any individual symptoms Table 2.

However, there was no significant difference in improvement between the two groups. The dehydration assessment scale improved from baseline in both hydration and placebo groups at day 4, although this was not observed at day 7 Table 2.

There was no significant difference between groups for the change in dehydration assessment scale from baseline at day 4 or day 7.

Overall survival by hydration status. The median survival was 21 days range, 13 to 29 days for the hydration group gold and 15 days range, 12 to 18 days for the placebo group blue , with a P value of.

Our study did not find parenteral hydration at 1, mL per day to be superior to placebo mL per day in improving symptoms associated with dehydration, QoL, or survival in terminally ill patients with cancer receiving home hospice care.

Both groups reported similar degree of improvement in their symptoms. We also observed a trend for less deterioration in mental status in the hydration group.

One concern regarding the lack of observed difference between groups is that the volume of hydration may have been too low.

This volume was specifically chosen based on our understanding that terminally ill patients with cancer require lower hydration volume as a result of weight loss, decreased insensible losses, decreased clearance of free water, and advanced age.

Rather, the short duration of hydration and a large placebo effect may account for the lack of observed differences.

Another limitation of this study is the fact that we excluded patients with severe dehydration eg, hemodynamic instability, altered mentation because these individuals tend to be acutely ill and in severe distress, making it difficult to obtain informed consent, deliver the study interventions, and keep them on study.

Because some of these patients may have benefited the most from parenteral hydration, future studies may consider inclusion of this subgroup.

Although we observed no significant between-group differences in the primary outcome, both groups demonstrated significant improvements in before-and-after comparison and similar levels of perceived overall benefit.

These findings are similar to our previous hydration study 3 and suggest that independent of the amount of hydration received, frequent visits and assessments by research nurses may result in significant improvement in the perception of overall benefit, to the extent that it may even overshadow the biomedical effect of hydration.

One possible way to circumvent the potential dramatic effect of nursing interventions may be by training family members to administer fluids and limiting the frequency of phone calls and assessments to the first and last day of study.

In addition to our clinical findings reported here, we were also able to collect patient and family perceptions of hydration, which we published recently.

Our group has also observed a large placebo effect in other types of symptom control studies.

One critical argument related to hydration in terminally ill patients concerns the relationship between delirium and hydration status.

Delirium is common and progressive at the end of life and causes immense distress to patients and families. This is not surprising given the trajectory of illness and the fact that we excluded patients with delirium upfront ie, limited room for improvement.

Interestingly, we observed a trend for lesser decline in the hydration group and significant worsening of nighttime NuDesc scores in the placebo group.

Future studies may need to include patients with delirium, who may actually benefit the most from hydration. This could be done by either obtaining informed consent before this complication occurs or by using proxy consent.

The overall median survival for study participants was 17 days, which is similar to the life expectancy of hospice patients across the United States.

Consistent with other studies, 6 , 42 — 46 our study suggests that patients with a short life expectancy may not benefit from hydration in regard to survival.

Our study suggests that placebo-controlled interventional trials are feasible in the hospice setting.

Supportive care trials are rarely done in this setting, 47 out of the ethical concern that these trials may be too burdensome for patients and families and that many would decline enrollment.

Although current hospice regulations precludes patients who elect hospice from participating in disease-modifying clinical trials, supportive care studies with the potential to improve symptoms and QoL should be encouraged.

Our study had several limitations. First, our planned sample size was patients, but because of funding issues, we terminated the study after patients.

The power to detect statistical significance given the found values and sample sizes was 4. Second, we conducted testing for multiple outcomes.

Thus P values close to. Third, we excluded patients with severe dehydration, as discussed previously. Future studies should include careful measurement of oral intake.

In conclusion, our results suggest that in patients with advanced cancer who are mildly to moderately dehydrated and within days to weeks of death, parenteral hydration at 1, mL per day does not improve symptoms associated with dehydration, QoL, or survival as compared with placebo.

Our study supports current hospice practice of not administering hydration routinely. Further studies are required to determine whether any subgroups, such as delirious patients or those with longer survival, would benefit from parenteral hydration.

Supported by Grant No. CA , an institutional startup fund D. The sponsor of the study had no role in study design, data collection, analysis, interpretation, or writing of the report.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article. Conception and design: Eduardo Bruera, J.

Lynn Palmer. National Center for Biotechnology Information , U. J Clin Oncol. Published online Nov Find articles by Eduardo Bruera.

Find articles by David Hui. Find articles by Shalini Dalal. Find articles by Isabel Torres-Vigil.

Find articles by Joseph Trumble. Find articles by Joseph Roosth. Find articles by Susan Krauter. Find articles by Carol Strickland. Find articles by Kenneth Unger.

Find articles by J. Find articles by Julio Allo. Find articles by Susan Frisbee-Hume. Find articles by Kenneth Tarleton.

Author information Copyright and License information Disclaimer. This article has been cited by other articles in PMC.

Associated Data Supplementary Materials Protocol. Abstract Purpose The vast majority of patients with cancer at the end of life receive parenteral hydration in hospitals and no hydration in hospice, with limited evidence supporting either practice.

Patients and Methods We randomly assigned patients with cancer from six hospices to receive parenteral hydration normal saline 1 L per day or placebo normal saline mL per day daily over 4 hours.

Before Dawn charts the years of exile in the life of famous Jewish Austrian writer Stefan Zweig, his inner struggle for the "right attitude" toward the events in war torn Europe, and his search for a new home.

Colognian commissioner Gereon Rath moves to Berlin, the epicenter of political and social changes in the Golden Twenties.

Explore the Kennedy family's rise to power and how personal relationships within the Kennedy dynasty shaped national and global events from the Cold War to the Wall Street crash.

Yves is living in hiding with his sons, Sylvain and Pierre. Two years before, he had abducted them from their mother after a judge ruled against him.

But the boys are growing up now, and The story of a single mother struggling to regain control of her life.

While living rough in a forest she fights to find a place in the world for her and her son, but her earnest attempts are continually thwarted.

Forget water, oil and rare earths - there is a new resource everyone wants: our time. This documentary investigates how time has become money, and how we can claim back control over this precious but finite resource.

Sandra returns to her childhood village to take care of family business, but her childhood memories and secrets soon overcome her.

The eight-part series follows the fates of extraordinary men, women and children from France, Germany, Italy, Great Britain, Austria, Sweden, Poland and the Soviet Union using their own diary entries, letters and memoirs.

These are people drawn into the war by their convictions, who with their loves and decisions bring the history of Europe with all its contradictions to life.

Written by Jan Peter and Gunnar Dedio. One of the most educating mini series, about the times between the ww1 and ww2 So many stories according to people who lived the hard times events Videos and photos of real places and events.

Sign In. Keep track of everything you watch; tell your friends. Full Cast and Crew. Release Dates.

Official Sites. Company Credits. Technical Specs. Episode List. Plot Summary. Plot Keywords.

Parents Guide. External Sites. User Reviews. User Ratings. External Reviews. Metacritic Reviews.

Photo Gallery. Trailers and Videos. Crazy Credits. Alternate Versions. Rate This. Episode Guide. The eight-part series follows the fates of extraordinary men, women and children Creators: Gunnar Dedio , Jan Peter.

Added to Watchlist. Top-Rated Episodes S1. Error: please try again. Everything New on Netflix in June. The War Movies. Watched in Best Mini Series.

Start , wishlist TV Shows. Use the HTML below. You must be a registered user to use the IMDb rating plugin.

Episodes Seasons. Hans Beimler 5 episodes, Michalina Olszanska May Picqueray 3 episodes, Natalia Witmer Marina Yurlova 3 episodes, Joel Basman Silvio Crespi 3 episodes, Luc Feit Heester 3 episodes, Thomas Arnold Marcel Jamet 3 episodes, Roxane Duran Edith Wellspacher 3 episodes, Emilie Gavois-Kahn Doriane Jamet 3 episodes, Philip York David Baron Redsdale 3 episodes, Jude Mack Diana Mitford 3 episodes, Jean-Marc Roulot Jean de l'Hermitage 3 episodes, Malgorzata Zajaczkowska Eleonora 3 episodes, Wolfgang Menardi Max Wachstein 3 episodes, Charlotte Merriam Elise Ottesen 2 episodes, Alexandre Nguyen Nguyen Ai Quoc 2 episodes, Anne Kulbatzki Magdalena Müller 2 episodes, Shanti Roney Albert 2 episodes, Roland Bonjour Ernst Lubitsch 2 episodes, Jules Werner Rut 2 episodes, Pyotr Skvortsov Stepan Podlubny 2 episodes, Gemma Lawrence Jessica Mitford 2 episodes, Andreas Lust Adalbert Springer 2 episodes, Gotthard Lange Film Agent 2 episodes, Alexandre Marine

Documentary History. Both groups reported similar degree of improvement in their symptoms. Official Sites. Dramdocumentary based on letters and journals, many of which have never been published before, this tells the story of solely through the eyes of click here who lived through it. Because of funding limitations, this study was terminated after patients were enrolled. Spamelot Schauspielhaus Bochum. Filme click here Ostermontag Hier erhaltet ihr Informationen zu einer Vielzahl von deutschen und deutschsprachigen Filmen. Der Balkon Staatstheater Stuttgart. Cursed — Die Auserwählte: Die ersten Bilder. Der Bau Staatstheater Stuttgart. Neue 3 der mazdaDeutschland, Niedersachsen. Jan Krauter lebt in Berlin. Vita - Werbung Jahr. Paddenbett 6 Bochum Deutschland.

1 Comment on “Jan krauter”

Hinterlasse eine Antwort

Deine E-Mail-Adresse wird nicht veröffentlicht. Erforderliche Felder sind markiert *